Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 179 participants.
Also called NCT02248961
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 179 participants
- Registry
-
NCT02248961
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT02248961. Randomized; no masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2019-05-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
- Condition
- Arterial Hypertension
- Intervention (Drug)
- Fimasartan
- Intervention (Drug)
- Losartan
- Lead sponsor
- R-Pharm
- Collaborator
- Covance
- Collaborator
- Boryung Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct02248961- Content hash
063d0008ddb6e14fb8836ad99da480b695b7a6adccdc56a381702241fe67d061